Powder: -20°C for 3 years | In solvent: -80°C for 1 year
(E/Z)-Teriflunomide (Aubagio), a orally-available Pyrimidine Synthesis Inhibitor, is used to treat relapsing multiple sclerosis.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | In stock | $ 50.00 | |
50 mg | In stock | $ 57.00 | |
100 mg | In stock | $ 74.00 | |
200 mg | In stock | $ 97.00 |
Description | (E/Z)-Teriflunomide (Aubagio), a orally-available Pyrimidine Synthesis Inhibitor, is used to treat relapsing multiple sclerosis. |
In vitro | In animal models of demyelinating diseases, Teriflunomide has demonstrated efficacy. For instance, in the black rat model of autoimmune encephalomyelitis, Teriflunomide has shown both preventive and therapeutic effects; similarly, in female Lewis rat models of Experimental Autoimmune Encephalomyelitis (EAE), it has been effective in ameliorating symptoms and reducing disease exacerbation. |
In vivo | Teriflunomide acts as a dihydroorotate dehydrogenase inhibitor, thereby inhibiting the de novo synthesis of pyrimidine in rapidly proliferating cells. By suppressing highly proliferative T and B lymphocytes, Teriflunomide effectively reduces the inflammatory response to self-antigens. |
Synonyms | Aubagio, HMR-1726, Flucyamide, A77 1726 |
Molecular Weight | 270.21 |
Formula | C12H9F3N2O2 |
CAS No. | 108605-62-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 27 mg/mL (100 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
(E/Z)-Teriflunomide 108605-62-5 Metabolism Dehydrogenase Teriflunomide HMR1726 Aubagio HMR-1726 Flucyamide A77 1726 HMR 1726 inhibitor inhibit